THE DEAL, AT A GLANCE
From the announcementRecursion Pharmaceuticals
01Who is involvedBacked by Various (IPO)From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedRecursion Pharmaceuticals raised $436M IPOFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersRecursion Pharmaceuticals is using IPO capital to scale an AI drug discovery model built on robotic biology, machine learning, and high-volume experimental data…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Recursion Pharmaceuticals · Financing Record
Explore source-linked visual explanations for Recursion Pharmaceuticals. Unsupported claims are withheld while source review continues.
Record 793 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →